Global Leber's Hereditary Optic Neuropathy Drug Market Growth 2024-2031

Report ID: 1503609 | Published Date: Jan 2025 | No. of Page: 94 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Leber's Hereditary Optic Neuropathy Drug Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Leber's Hereditary Optic Neuropathy Drug by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Leber's Hereditary Optic Neuropathy Drug by Country/Region, 2017, 2022 & 2028
    2.2 Leber's Hereditary Optic Neuropathy Drug Segment by Type
        2.2.1 Elamipretide
        2.2.2 GS-011
        2.2.3 IXC-201
        2.2.4 KH-176
        2.2.5 Others
    2.3 Leber's Hereditary Optic Neuropathy Drug Sales by Type
        2.3.1 Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2017-2022)
        2.3.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Leber's Hereditary Optic Neuropathy Drug Sale Price by Type (2017-2022)
    2.4 Leber's Hereditary Optic Neuropathy Drug Segment by Application
        2.4.1 Hospital
        2.4.2 Clinic
        2.4.3 Others
    2.5 Leber's Hereditary Optic Neuropathy Drug Sales by Application
        2.5.1 Global Leber's Hereditary Optic Neuropathy Drug Sale Market Share by Application (2017-2022)
        2.5.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Leber's Hereditary Optic Neuropathy Drug Sale Price by Application (2017-2022)
3 Global Leber's Hereditary Optic Neuropathy Drug by Company
    3.1 Global Leber's Hereditary Optic Neuropathy Drug Breakdown Data by Company
        3.1.1 Global Leber's Hereditary Optic Neuropathy Drug Annual Sales by Company (2020-2022)
        3.1.2 Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Company (2020-2022)
    3.2 Global Leber's Hereditary Optic Neuropathy Drug Annual Revenue by Company (2020-2022)
        3.2.1 Global Leber's Hereditary Optic Neuropathy Drug Revenue by Company (2020-2022)
        3.2.2 Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Company (2020-2022)
    3.3 Global Leber's Hereditary Optic Neuropathy Drug Sale Price by Company
    3.4 Key Manufacturers Leber's Hereditary Optic Neuropathy Drug Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Leber's Hereditary Optic Neuropathy Drug Product Location Distribution
        3.4.2 Players Leber's Hereditary Optic Neuropathy Drug Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Leber's Hereditary Optic Neuropathy Drug by Geographic Region
    4.1 World Historic Leber's Hereditary Optic Neuropathy Drug Market Size by Geographic Region (2017-2022)
        4.1.1 Global Leber's Hereditary Optic Neuropathy Drug Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Leber's Hereditary Optic Neuropathy Drug Annual Revenue by Geographic Region
    4.2 World Historic Leber's Hereditary Optic Neuropathy Drug Market Size by Country/Region (2017-2022)
        4.2.1 Global Leber's Hereditary Optic Neuropathy Drug Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Leber's Hereditary Optic Neuropathy Drug Annual Revenue by Country/Region
    4.3 Americas Leber's Hereditary Optic Neuropathy Drug Sales Growth
    4.4 APAC Leber's Hereditary Optic Neuropathy Drug Sales Growth
    4.5 Europe Leber's Hereditary Optic Neuropathy Drug Sales Growth
    4.6 Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales Growth
5 Americas
    5.1 Americas Leber's Hereditary Optic Neuropathy Drug Sales by Country
        5.1.1 Americas Leber's Hereditary Optic Neuropathy Drug Sales by Country (2017-2022)
        5.1.2 Americas Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2017-2022)
    5.2 Americas Leber's Hereditary Optic Neuropathy Drug Sales by Type
    5.3 Americas Leber's Hereditary Optic Neuropathy Drug Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Leber's Hereditary Optic Neuropathy Drug Sales by Region
        6.1.1 APAC Leber's Hereditary Optic Neuropathy Drug Sales by Region (2017-2022)
        6.1.2 APAC Leber's Hereditary Optic Neuropathy Drug Revenue by Region (2017-2022)
    6.2 APAC Leber's Hereditary Optic Neuropathy Drug Sales by Type
    6.3 APAC Leber's Hereditary Optic Neuropathy Drug Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Leber's Hereditary Optic Neuropathy Drug by Country
        7.1.1 Europe Leber's Hereditary Optic Neuropathy Drug Sales by Country (2017-2022)
        7.1.2 Europe Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2017-2022)
    7.2 Europe Leber's Hereditary Optic Neuropathy Drug Sales by Type
    7.3 Europe Leber's Hereditary Optic Neuropathy Drug Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Leber's Hereditary Optic Neuropathy Drug by Country
        8.1.1 Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2017-2022)
    8.2 Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Type
    8.3 Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Leber's Hereditary Optic Neuropathy Drug
    10.3 Manufacturing Process Analysis of Leber's Hereditary Optic Neuropathy Drug
    10.4 Industry Chain Structure of Leber's Hereditary Optic Neuropathy Drug
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Leber's Hereditary Optic Neuropathy Drug Distributors
    11.3 Leber's Hereditary Optic Neuropathy Drug Customer
12 World Forecast Review for Leber's Hereditary Optic Neuropathy Drug by Geographic Region
    12.1 Global Leber's Hereditary Optic Neuropathy Drug Market Size Forecast by Region
        12.1.1 Global Leber's Hereditary Optic Neuropathy Drug Forecast by Region (2023-2028)
        12.1.2 Global Leber's Hereditary Optic Neuropathy Drug Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Leber's Hereditary Optic Neuropathy Drug Forecast by Type
    12.7 Global Leber's Hereditary Optic Neuropathy Drug Forecast by Application
13 Key Players Analysis
    13.1 Alkeus Pharmaceuticals, Inc.
        13.1.1 Alkeus Pharmaceuticals, Inc. Company Information
        13.1.2 Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Product Offered
        13.1.3 Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Alkeus Pharmaceuticals, Inc. Main Business Overview
        13.1.5 Alkeus Pharmaceuticals, Inc. Latest Developments
    13.2 Biovista Inc.
        13.2.1 Biovista Inc. Company Information
        13.2.2 Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Product Offered
        13.2.3 Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Biovista Inc. Main Business Overview
        13.2.5 Biovista Inc. Latest Developments
    13.3 GenSight Biologics S.A.
        13.3.1 GenSight Biologics S.A. Company Information
        13.3.2 GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Product Offered
        13.3.3 GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 GenSight Biologics S.A. Main Business Overview
        13.3.5 GenSight Biologics S.A. Latest Developments
    13.4 Ixchel Pharma, LLC
        13.4.1 Ixchel Pharma, LLC Company Information
        13.4.2 Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Product Offered
        13.4.3 Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Ixchel Pharma, LLC Main Business Overview
        13.4.5 Ixchel Pharma, LLC Latest Developments
    13.5 Khondrion BV
        13.5.1 Khondrion BV Company Information
        13.5.2 Khondrion BV Leber's Hereditary Optic Neuropathy Drug Product Offered
        13.5.3 Khondrion BV Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Khondrion BV Main Business Overview
        13.5.5 Khondrion BV Latest Developments
    13.6 Spark Therapeutics, Inc.
        13.6.1 Spark Therapeutics, Inc. Company Information
        13.6.2 Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Product Offered
        13.6.3 Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Spark Therapeutics, Inc. Main Business Overview
        13.6.5 Spark Therapeutics, Inc. Latest Developments
    13.7 Stealth BioTherapeutics Inc.
        13.7.1 Stealth BioTherapeutics Inc. Company Information
        13.7.2 Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Product Offered
        13.7.3 Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Stealth BioTherapeutics Inc. Main Business Overview
        13.7.5 Stealth BioTherapeutics Inc. Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Leber's Hereditary Optic Neuropathy Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Leber's Hereditary Optic Neuropathy Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Elamipretide
    Table 4. Major Players of GS-011
    Table 5. Major Players of IXC-201
    Table 6. Major Players of KH-176
    Table 7. Major Players of Others
    Table 8. Global Leber's Hereditary Optic Neuropathy Drug Sales by Type (2017-2022) & (K Pcs)
    Table 9. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2017-2022)
    Table 10. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2017-2022) & ($ million)
    Table 11. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Type (2017-2022)
    Table 12. Global Leber's Hereditary Optic Neuropathy Drug Sale Price by Type (2017-2022) & (USD/Pcs)
    Table 13. Global Leber's Hereditary Optic Neuropathy Drug Sales by Application (2017-2022) & (K Pcs)
    Table 14. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2017-2022)
    Table 15. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Application (2017-2022)
    Table 16. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Application (2017-2022)
    Table 17. Global Leber's Hereditary Optic Neuropathy Drug Sale Price by Application (2017-2022) & (USD/Pcs)
    Table 18. Global Leber's Hereditary Optic Neuropathy Drug Sales by Company (2020-2022) & (K Pcs)
    Table 19. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Company (2020-2022)
    Table 20. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Company (2020-2022) ($ Millions)
    Table 21. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Company (2020-2022)
    Table 22. Global Leber's Hereditary Optic Neuropathy Drug Sale Price by Company (2020-2022) & (USD/Pcs)
    Table 23. Key Manufacturers Leber's Hereditary Optic Neuropathy Drug Producing Area Distribution and Sales Area
    Table 24. Players Leber's Hereditary Optic Neuropathy Drug Products Offered
    Table 25. Leber's Hereditary Optic Neuropathy Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 26. New Products and Potential Entrants
    Table 27. Mergers & Acquisitions, Expansion
    Table 28. Global Leber's Hereditary Optic Neuropathy Drug Sales by Geographic Region (2017-2022) & (K Pcs)
    Table 29. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share Geographic Region (2017-2022)
    Table 30. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 31. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Geographic Region (2017-2022)
    Table 32. Global Leber's Hereditary Optic Neuropathy Drug Sales by Country/Region (2017-2022) & (K Pcs)
    Table 33. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country/Region (2017-2022)
    Table 34. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Country/Region (2017-2022) & ($ millions)
    Table 35. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country/Region (2017-2022)
    Table 36. Americas Leber's Hereditary Optic Neuropathy Drug Sales by Country (2017-2022) & (K Pcs)
    Table 37. Americas Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country (2017-2022)
    Table 38. Americas Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2017-2022) & ($ Millions)
    Table 39. Americas Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country (2017-2022)
    Table 40. Americas Leber's Hereditary Optic Neuropathy Drug Sales by Type (2017-2022) & (K Pcs)
    Table 41. Americas Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2017-2022)
    Table 42. Americas Leber's Hereditary Optic Neuropathy Drug Sales by Application (2017-2022) & (K Pcs)
    Table 43. Americas Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2017-2022)
    Table 44. APAC Leber's Hereditary Optic Neuropathy Drug Sales by Region (2017-2022) & (K Pcs)
    Table 45. APAC Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Region (2017-2022)
    Table 46. APAC Leber's Hereditary Optic Neuropathy Drug Revenue by Region (2017-2022) & ($ Millions)
    Table 47. APAC Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Region (2017-2022)
    Table 48. APAC Leber's Hereditary Optic Neuropathy Drug Sales by Type (2017-2022) & (K Pcs)
    Table 49. APAC Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2017-2022)
    Table 50. APAC Leber's Hereditary Optic Neuropathy Drug Sales by Application (2017-2022) & (K Pcs)
    Table 51. APAC Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2017-2022)
    Table 52. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Country (2017-2022) & (K Pcs)
    Table 53. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country (2017-2022)
    Table 54. Europe Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2017-2022) & ($ Millions)
    Table 55. Europe Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country (2017-2022)
    Table 56. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Type (2017-2022) & (K Pcs)
    Table 57. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2017-2022)
    Table 58. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Application (2017-2022) & (K Pcs)
    Table 59. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2017-2022)
    Table 60. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Country (2017-2022) & (K Pcs)
    Table 61. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country (2017-2022)
    Table 62. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Revenue by Country (2017-2022) & ($ Millions)
    Table 63. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country (2017-2022)
    Table 64. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Type (2017-2022) & (K Pcs)
    Table 65. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type (2017-2022)
    Table 66. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Application (2017-2022) & (K Pcs)
    Table 67. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2017-2022)
    Table 68. Key Market Drivers & Growth Opportunities of Leber's Hereditary Optic Neuropathy Drug
    Table 69. Key Market Challenges & Risks of Leber's Hereditary Optic Neuropathy Drug
    Table 70. Key Industry Trends of Leber's Hereditary Optic Neuropathy Drug
    Table 71. Leber's Hereditary Optic Neuropathy Drug Raw Material
    Table 72. Key Suppliers of Raw Materials
    Table 73. Leber's Hereditary Optic Neuropathy Drug Distributors List
    Table 74. Leber's Hereditary Optic Neuropathy Drug Customer List
    Table 75. Global Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 76. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Forecast by Region
    Table 77. Global Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 78. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share Forecast by Region (2023-2028)
    Table 79. Americas Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 80. Americas Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 81. APAC Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 82. APAC Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 83. Europe Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 84. Europe Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 85. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 86. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 87. Global Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 88. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share Forecast by Type (2023-2028)
    Table 89. Global Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 90. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share Forecast by Type (2023-2028)
    Table 91. Global Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 92. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share Forecast by Application (2023-2028)
    Table 93. Global Leber's Hereditary Optic Neuropathy Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 94. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share Forecast by Application (2023-2028)
    Table 95. Alkeus Pharmaceuticals, Inc. Basic Information, Leber's Hereditary Optic Neuropathy Drug Manufacturing Base, Sales Area and Its Competitors
    Table 96. Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Product Offered
    Table 97. Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 98. Alkeus Pharmaceuticals, Inc. Main Business
    Table 99. Alkeus Pharmaceuticals, Inc. Latest Developments
    Table 100. Biovista Inc. Basic Information, Leber's Hereditary Optic Neuropathy Drug Manufacturing Base, Sales Area and Its Competitors
    Table 101. Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Product Offered
    Table 102. Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 103. Biovista Inc. Main Business
    Table 104. Biovista Inc. Latest Developments
    Table 105. GenSight Biologics S.A. Basic Information, Leber's Hereditary Optic Neuropathy Drug Manufacturing Base, Sales Area and Its Competitors
    Table 106. GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Product Offered
    Table 107. GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 108. GenSight Biologics S.A. Main Business
    Table 109. GenSight Biologics S.A. Latest Developments
    Table 110. Ixchel Pharma, LLC Basic Information, Leber's Hereditary Optic Neuropathy Drug Manufacturing Base, Sales Area and Its Competitors
    Table 111. Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Product Offered
    Table 112. Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 113. Ixchel Pharma, LLC Main Business
    Table 114. Ixchel Pharma, LLC Latest Developments
    Table 115. Khondrion BV Basic Information, Leber's Hereditary Optic Neuropathy Drug Manufacturing Base, Sales Area and Its Competitors
    Table 116. Khondrion BV Leber's Hereditary Optic Neuropathy Drug Product Offered
    Table 117. Khondrion BV Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 118. Khondrion BV Main Business
    Table 119. Khondrion BV Latest Developments
    Table 120. Spark Therapeutics, Inc. Basic Information, Leber's Hereditary Optic Neuropathy Drug Manufacturing Base, Sales Area and Its Competitors
    Table 121. Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Product Offered
    Table 122. Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 123. Spark Therapeutics, Inc. Main Business
    Table 124. Spark Therapeutics, Inc. Latest Developments
    Table 125. Stealth BioTherapeutics Inc. Basic Information, Leber's Hereditary Optic Neuropathy Drug Manufacturing Base, Sales Area and Its Competitors
    Table 126. Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Product Offered
    Table 127. Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 128. Stealth BioTherapeutics Inc. Main Business
    Table 129. Stealth BioTherapeutics Inc. Latest Developments
List of Figures
    Figure 1. Picture of Leber's Hereditary Optic Neuropathy Drug
    Figure 2. Leber's Hereditary Optic Neuropathy Drug Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Leber's Hereditary Optic Neuropathy Drug Sales Growth Rate 2017-2028 (K Pcs)
    Figure 7. Global Leber's Hereditary Optic Neuropathy Drug Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Leber's Hereditary Optic Neuropathy Drug Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Elamipretide
    Figure 10. Product Picture of GS-011
    Figure 11. Product Picture of IXC-201
    Figure 12. Product Picture of KH-176
    Figure 13. Product Picture of Others
    Figure 14. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Type in 2021
    Figure 15. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Type (2017-2022)
    Figure 16. Leber's Hereditary Optic Neuropathy Drug Consumed in Hospital
    Figure 17. Global Leber's Hereditary Optic Neuropathy Drug Market: Hospital (2017-2022) & (K Pcs)
    Figure 18. Leber's Hereditary Optic Neuropathy Drug Consumed in Clinic
    Figure 19. Global Leber's Hereditary Optic Neuropathy Drug Market: Clinic (2017-2022) & (K Pcs)
    Figure 20. Leber's Hereditary Optic Neuropathy Drug Consumed in Others
    Figure 21. Global Leber's Hereditary Optic Neuropathy Drug Market: Others (2017-2022) & (K Pcs)
    Figure 22. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application (2017-2022)
    Figure 23. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Application in 2021
    Figure 24. Leber's Hereditary Optic Neuropathy Drug Revenue Market by Company in 2021 ($ Million)
    Figure 25. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Company in 2021
    Figure 26. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Geographic Region (2017-2022)
    Figure 27. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Geographic Region in 2021
    Figure 28. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Region (2017-2022)
    Figure 29. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country/Region in 2021
    Figure 30. Americas Leber's Hereditary Optic Neuropathy Drug Sales 2017-2022 (K Pcs)
    Figure 31. Americas Leber's Hereditary Optic Neuropathy Drug Revenue 2017-2022 ($ Millions)
    Figure 32. APAC Leber's Hereditary Optic Neuropathy Drug Sales 2017-2022 (K Pcs)
    Figure 33. APAC Leber's Hereditary Optic Neuropathy Drug Revenue 2017-2022 ($ Millions)
    Figure 34. Europe Leber's Hereditary Optic Neuropathy Drug Sales 2017-2022 (K Pcs)
    Figure 35. Europe Leber's Hereditary Optic Neuropathy Drug Revenue 2017-2022 ($ Millions)
    Figure 36. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales 2017-2022 (K Pcs)
    Figure 37. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Revenue 2017-2022 ($ Millions)
    Figure 38. Americas Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country in 2021
    Figure 39. Americas Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country in 2021
    Figure 40. United States Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 41. Canada Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Mexico Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 43. Brazil Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 44. APAC Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Region in 2021
    Figure 45. APAC Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Regions in 2021
    Figure 46. China Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Japan Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 48. South Korea Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Southeast Asia Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 50. India Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 51. Australia Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country in 2021
    Figure 53. Europe Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country in 2021
    Figure 54. Germany Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 55. France Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 56. UK Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 57. Italy Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Russia Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Country in 2021
    Figure 60. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Country in 2021
    Figure 61. Egypt Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 62. South Africa Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Israel Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 64. Turkey Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 65. GCC Country Leber's Hereditary Optic Neuropathy Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 66. Manufacturing Cost Structure Analysis of Leber's Hereditary Optic Neuropathy Drug in 2021
    Figure 67. Manufacturing Process Analysis of Leber's Hereditary Optic Neuropathy Drug
    Figure 68. Industry Chain Structure of Leber's Hereditary Optic Neuropathy Drug
    Figure 69. Channels of Distribution
    Figure 70. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Leber's Hereditary Optic Neuropathy Drug Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Leber's Hereditary Optic Neuropathy Drug Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Leber's Hereditary Optic Neuropathy Drug Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports